Navellier & Associates Inc Johnson & Johnson Transaction History

Navellier & Associates Inc

$839 Million
Q2 2024

A detailed history of Navellier & Associates Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Navellier & Associates Inc holds 18,058 shares of JNJ stock, worth $2.89 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

18,058

Previous 18,158 0.55%

Holding current value

$2.89 Million

Previous $2.87 Million 8.11%

% of portfolio

0.31%

Previous 0.36%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$144.38 - $157.78 $14,438 - $15,778	-100 Reduced 0.55%	18,058 $2.64 Million
Q4 2023 Feb 08, 2024	BUY	$145.6 - $158.88 $126,235 - $137,748	867 Added 5.01%	18,158 $2.85 Million
Q3 2023 Nov 09, 2023	BUY	$155.75 - $174.48 $2.43 Million - $2.72 Million	15,591 Added 917.12%	17,291 $2.69 Million
Q2 2023 Aug 07, 2023	BUY	$154.35 - $166.11 $30,870 - $33,222	200 Added 13.33%	1,700 $281,000
Q1 2023 May 12, 2023	SELL	$151.05 - $180.26 $15,105 - $18,026	-100 Reduced 6.25%	1,500 $232,000
Q4 2022 Feb 02, 2023	BUY	$160.2 - $179.79 $16,019 - $17,979	100 Added 6.67%	1,600 $282,000
Q3 2022 Nov 09, 2022	SELL	$161.33 - $179.52 $32,266 - $35,904	-200 Reduced 11.76%	1,500 $245,000
Q1 2022 Apr 29, 2022	SELL	$158.14 - $179.59 $15,813 - $17,959	-100 Reduced 5.56%	1,700 $301,000
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $15,593 - $17,301	-100 Reduced 5.26%	1,800 $308,000
Q2 2021 Aug 09, 2021	BUY	$159.48 - $171.07 $15,947 - $17,107	100 Added 5.56%	1,900 $313,000
Q1 2021 May 12, 2021	SELL	$153.07 - $170.48 $37,042 - $41,256	-242 Reduced 11.85%	1,800 $296,000
Q1 2020 May 13, 2020	SELL	$111.14 - $153.99 $44,456 - $61,596	-400 Reduced 16.38%	2,042 $268,000
Q4 2019 Feb 12, 2020	BUY	$127.5 - $146.44 $38,250 - $43,932	300 Added 14.01%	2,442 $356,000
Q3 2019 Oct 16, 2019	BUY	$126.95 - $142.14 $25,390 - $28,427	200 Added 10.3%	2,142 $277,000
Q2 2019 Jul 17, 2019	BUY	$131.15 - $144.24 $13,115 - $14,424	100 Added 5.43%	1,942 $270,000
Q1 2019 May 15, 2019	BUY	$125.72 - $139.79 $12,572 - $13,979	100 Added 5.74%	1,842 $257,000
Q4 2018 Jan 15, 2019	SELL	$122.84 - $147.84 $12,284 - $14,784	-100 Reduced 5.43%	1,742 $225,000
Q3 2018 Nov 14, 2018	SELL	$121.58 - $142.88 $69,908 - $82,156	-575 Reduced 23.79%	1,842 $255,000
Q2 2018 Aug 06, 2018	SELL	$119.4 - $131.76 $18,865 - $20,818	-158 Reduced 6.14%	2,417 $293,000
Q1 2018 May 21, 2018	SELL	$125.1 - $148.14 $235,188 - $278,503	-1,880 Reduced 42.2%	2,575 $330,000
Q4 2017 Feb 12, 2018	SELL	$131.22 - $143.62 $707,013 - $773,824	-5,388 Reduced 54.74%	4,455 $623,000
Q3 2017 Nov 14, 2017	SELL	$129.47 - $135.38 $462,596 - $483,712	-3,573 Reduced 26.63%	9,843 $1.28 Million
Q2 2017 Aug 24, 2017	BUY	N/A	13,416	13,416 $1.78 Million

Others Institutions Holding JNJ

# of Institutions

4,210

Shares Held

1.7B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $419B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Navellier & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Navellier & Associates Inc with notifications on news.

Account

Navellier & Associates Inc Johnson & Johnson Transaction History